BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32160452)

  • 1. Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
    Zajkowska M; Gacuta E; Lubowicka E; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2020 Mar; 67(1):25-29. PubMed ID: 32160452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
    Zajkowska M; Lubowicka E; Malinowski P; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2018 Dec; 65(4):621-628. PubMed ID: 30543720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
    Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
    Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Biomarkers; 2017 Mar; 22(2):157-164. PubMed ID: 27775427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S; Głażewska EK; Sobolewska M; Będkowska GE; Szmitkowski M
    Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
    Zajkowska M; Gacuta E; Kozłowska S; Lubowicka E; Głażewska EK; Chrostek L; Szmitkowski M; Pawłowski P; Zbucka-Krętowska M; Ławicki S
    Adv Med Sci; 2019 Mar; 64(1):1-8. PubMed ID: 30227310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.
    Dąbrowska E; Przylipiak A; Zajkowska M; Piskór BM; Borowik-Zaręba A; Ławicki S
    Acta Biochim Pol; 2020 Nov; 67(4):539-449. PubMed ID: 33245226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.
    Lubowicka E; Przylipiak A; Zajkowska M; Piskór BM; Malinowski P; Fiedorowicz W; Ławicki S
    Biomed Res Int; 2018; 2018():2124390. PubMed ID: 30151375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S; Szmitkowski M; Wojtukiewicz M
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S; Będkowska GE; Szmitkowski M
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2010; 67(12):1314-8. PubMed ID: 21591359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Onco Targets Ther; 2016; 9():911-9. PubMed ID: 26966379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
    Zajkowska M; Głażewska EK; Będkowska GE; Chorąży P; Szmitkowski M; Ławicki S
    Mediators Inflamm; 2016; 2016():5962946. PubMed ID: 27445439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
    Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
    Ławicki S; Czygier M; Bedkowska E; Wojtukiewicz M; Szmitkowski M
    Pol Arch Med Wewn; 2008 Sep; 118(9):464-9. PubMed ID: 18846980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
    Nour Eldin EEM; El-Readi MZ; Nour Eldein MM; Alfalki AA; Althubiti MA; Mohamed Kamel HF; Eid SY; Al-Amodi HS; Mirza AA
    Clin Breast Cancer; 2019 Apr; 19(2):e385-e393. PubMed ID: 30683611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.